By Professor Andrew Stewart Day

Journal articles

Vernon-Roberts A; Denny A; Day AS, 2023, 'Point Prevalence of Complementary or Alternative Medicine Use among Children Attending a Tertiary Care Hospital', Children, 10, http://dx.doi.org/10.3390/children10010132

Vernon-Roberts A; Day AS, 2023, 'Promoting early testing and appropriate referral to reduce diagnostic delay for children with suspected inflammatory bowel disease, a narrative review', Translational Pediatrics, 12, pp. 1416 - 1430, http://dx.doi.org/10.21037/tp-23-35

Moton TM; King PT; Dalziel SR; Merry S; Robertson SP; Day AS, 2023, 'The current and future state of child health and wellbeing in Aotearoa New Zealand: Part 2', Journal of the Royal Society of New Zealand, 53, pp. 549 - 552, http://dx.doi.org/10.1080/03036758.2023.2219409

Brown SC; Whelan K; Frampton C; Wall CL; Gearry RB; Day AS, 2023, 'Food-related quality of life in children and adolescents with Crohn Disease', Clinical Nutrition ESPEN, 58, pp. 751 - 751, http://dx.doi.org/10.1016/j.clnesp.2023.10.015

Katz T; Wakefield CE; Signorelli C; Day AS; Vernon-Roberts A; Ooi CY, 2023, 'P298 Gastroenterology services for patients with cystic fibrosis across Australia and New Zealand: a multi-stakeholder assessment of patients’ and professionals’ perspectives', Journal of Cystic Fibrosis, 22, pp. S156 - S156, http://dx.doi.org/10.1016/s1569-1993(23)00669-0

Forbes AJ; Day AS; Frampton C; Vernon-Roberts A; Gearry R, 2023, 'Tu2002 PAEDIATRIC INFLAMMATORY BOWEL DISEASE EPIDEMIOLOGY IN OCEANIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INCIDENCE AND PREVALENCE', Gastroenterology, 164, pp. S - 1183, http://dx.doi.org/10.1016/s0016-5085(23)03720-4

Ho SSC; Evans HM; Roberts AJ; Thapar N; Dutt S; Thacker K; Krishnan U; Ooi CY; Yap J; Sharma A; Day AS, 2022, 'Australasian paediatric gastroenterologist practices of coeliac disease diagnosis before and during the COVID-19 pandemic', Journal of Paediatrics and Child Health, 58, pp. 2280 - 2285, http://dx.doi.org/10.1111/jpc.16227

Swaminathan A; Borichevsky GM; Edwards TS; Hirschfeld E; Mules TC; Frampton CMA; Day AS; Hampton MB; Kettle AJ; Gearry RB, 2022, 'Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease', Journal of Crohn S and Colitis, 16, pp. 1862 - 1873, http://dx.doi.org/10.1093/ecco-jcc/jjac098

Brown SC; Whelan K; Frampton C; Wall CL; Gearry RB; Day AS, 2022, 'Food-Related Quality of Life in Children and Adolescents With Crohn's Disease', Inflammatory Bowel Diseases, 28, pp. 1838 - 1843, http://dx.doi.org/10.1093/ibd/izac010

Vernon-Roberts A; Lopez RN; Day AS, 2022, 'Taurolidine Versus Ethanol Central Line Locks for Children on Parenteral Nutrition', Journal of Pediatric Gastroenterology and Nutrition, 75, pp. E119, http://dx.doi.org/10.1097/MPG.0000000000003565

Ho SSC; Keenan JI; Day AS, 2022, 'Urinary chitinase 3-like 1 and intestinal fatty-acid binding proteins are not elevated in children with inflammatory bowel disease', Intestinal Research, 20, pp. 509 - 513, http://dx.doi.org/10.5217/ir.2022.00064

Volkers AG; Appleton L; Gearry RB; Frampton CM; de Voogd FAE; Peters van Ton AM; Leach ST; Lemberg DA; Day AS, 2022, 'Fecal Calprotectin, Chitinase 3-Like-1, S100A12 and Osteoprotegerin as Markers of Disease Activity in Children with Crohn’s Disease', Gastrointestinal Disorders, 4, pp. 180 - 189, http://dx.doi.org/10.3390/gidisord4030017

Vernon-Roberts A; Lopez RN; Frampton CM; Day AS, 2022, 'Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition', Journal of Parenteral and Enteral Nutrition, 46, pp. 1535 - 1552, http://dx.doi.org/10.1002/jpen.2363

Varkaneh HK; Poursoleiman F; Al Masri MK; Alras KA; Shayah Y; Masmoum MD; Alangari FA; Alras AA; Rinaldi G; Day AS; Hekmatdoost A; Abu-Zaid A; Kutbi E, 2022, 'Low fat diet versus low carbohydrate diet for management of non-alcohol fatty liver disease: A systematic review', Frontiers in Nutrition, 9, http://dx.doi.org/10.3389/fnut.2022.987921

Brown S; Wall CL; Frampton C; Gearry RB; Day AS, 2022, 'Dietary Nutrient Intake and Blood Micronutrient Status of Children with Crohn’s Disease Compared with Their Shared-Home Environment, Healthy Siblings', Nutrients, 14, http://dx.doi.org/10.3390/nu14163425

Swaminathan A; Fan D; Borichevsky GM; Mules TC; Hirschfeld E; Frampton CM; Day AS; Siegel CA; Gearry RB, 2022, 'The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course', Alimentary Pharmacology and Therapeutics, 56, pp. 664 - 674, http://dx.doi.org/10.1111/apt.17058

Permain J; Appleton L; Ho SSC; Coffey M; Ooi CY; Keenan JI; Day AS, 2022, 'Children With Cystic Fibrosis Have Elevated Levels of Fecal Chitinase-3-like-1', Journal of Pediatric Gastroenterology and Nutrition, 75, pp. 48 - 51, http://dx.doi.org/10.1097/MPG.0000000000003477

Khalilipour BS; Day AS; Kenrick K; Schultz M; Aluzaite K, 2022, 'Diagnostic Delay in Paediatric Inflammatory Bowel Disease—A Systematic Investigation', Journal of Clinical Medicine, 11, http://dx.doi.org/10.3390/jcm11144161

Wong E; Lui K; Day AS; Leach ST, 2022, 'Manipulating the neonatal gut microbiome: current understanding and future perspectives', Archives of Disease in Childhood Fetal and Neonatal Edition, 107, pp. F346 - F350, http://dx.doi.org/10.1136/archdischild-2021-321922

Ho SSC; Keenan JI; Day AS, 2022, 'Patient perceptions of current and potential inflammatory bowel disease diagnostic and monitoring tests', Internal Medicine Journal, 52, pp. 1196 - 1202, http://dx.doi.org/10.1111/imj.15298

Day AS; Yao CK; Costello SP; Ruszkiewicz A; Andrews JM; Gibson PR; Bryant RV, 2022, 'Therapeutic Potential of the 4 Strategies to SUlfide-REduction (4-SURE) Diet in Adults with Mild to Moderately Active Ulcerative Colitis: An Open-Label Feasibility Study', Journal of Nutrition, 152, pp. 1690 - 1701, http://dx.doi.org/10.1093/jn/nxac093

Buerkle KS; Vernon-Roberts A; Ho C; Schultz M; Day AS, 2022, 'A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease', Digestive Diseases and Sciences, 67, pp. 2049 - 2058, http://dx.doi.org/10.1007/s10620-022-07507-7

Day AS; Bener A; Tewfik I; Vajro P; Zughaier SM, 2022, 'Editorial: The Role of Vitamin D in Gut Health and Disease in Children', Frontiers in Public Health, 10, http://dx.doi.org/10.3389/fpubh.2022.912773

Ho SSC; Hall S; Keenan JI; Day AS, 2022, 'Australasian Pediatric Gastroenterologists’ Perspectives and Practices of Celiac Disease Diagnosis and Management', Digestive Diseases and Sciences, 67, pp. 1744 - 1752, http://dx.doi.org/10.1007/s10620-021-06988-2

Vernon-Roberts A; Day AS, 2022, 'The Role of Vitamin D for Children with Inflammatory Bowel Disease', Recent Progress in Nutrition, 02, pp. 1 - 14, http://dx.doi.org/10.21926/rpn.2202013

Shaoul R; Lightdale JR; Day AS, 2022, 'Editorial: Pediatric Endoscopy and Sedation', Frontiers in Pediatrics, 10, http://dx.doi.org/10.3389/fped.2022.875156

Day AS; Yao CK; Costello SP; Andrews JM; Bryant RV, 2022, 'Food-related quality of life in adults with inflammatory bowel disease is associated with restrictive eating behaviour, disease activity and surgery: A prospective multicentre observational study', Journal of Human Nutrition and Dietetics, 35, pp. 234 - 244, http://dx.doi.org/10.1111/jhn.12920

Talebi S; Day AS; Rezaiyan MK; Ranjbar G; Zarei M; Safarian M; Kianifar HR, 2022, 'Fecal Calprotectin and Phenotype Severity in Patients with Cystic Fibrosis: A Systematic Review and Meta-Analysis', Pediatric Gastroenterology Hepatology and Nutrition, 25, pp. 1 - 12, http://dx.doi.org/10.5223/pghn.2022.25.1.1

Moton TM; King PT; Dalziel SR; Merry S; Robertson SP; Day AS, 2022, 'The current and future state of child health and wellbeing in Aotearoa New Zealand: part 1', Journal of the Royal Society of New Zealand, 52, pp. 313 - 317, http://dx.doi.org/10.1080/03036758.2022.2093434

Mules TC; Swaminathan A; Hirschfeld E; Borichevsky G; Frampton C; Day AS; Gearry RB, 2022, 'The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease—results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study', Alimentary Pharmacology and Therapeutics, 55, pp. 201 - 211, http://dx.doi.org/10.1111/apt.16616

Martin NG; Roberts AJ; Evans HM; Bishop J; Day AS, 2022, 'Adherence to the New Zealand Pediatric Guideline for the Assessment and Diagnosis of Inflammatory Bowel Disease.', JPGN Rep, 3, pp. e266, http://dx.doi.org/10.1097/PG9.0000000000000266

Shaoul R; Day AS, 2021, 'Pediatric Endoscopy During COVID-19 Times', Frontiers in Pediatrics, 9, http://dx.doi.org/10.3389/fped.2021.750717

Day AS; Yao CK; Costello SP; Andrews JM; Bryant RV, 2021, 'Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review', Appetite, 167, http://dx.doi.org/10.1016/j.appet.2021.105650

Vernon-Roberts A; Alexander I; Day AS, 2021, 'Systematic review of pediatric functional gastrointestinal disorders (Rome iv criteria)', Journal of Clinical Medicine, 10, http://dx.doi.org/10.3390/jcm10215087

Edwards TS; Dawson KL; Keenan JI; Day AS, 2021, 'A simple method to generate β-casomorphin-7 by in vitro digestion of casein from bovine milk', Journal of Functional Foods, 85, http://dx.doi.org/10.1016/j.jff.2021.104631

Lopez RN; Day AS, 2021, 'Editorial: the risk of chronic diseases and congenital malformations during childhood and adolescence after in utero drug exposure to thiopurines', Alimentary Pharmacology and Therapeutics, 54, pp. 1088 - 1089, http://dx.doi.org/10.1111/apt.16606

Day AS, 2021, 'Aspects of the Pathogenesis and Management of Inflammatory Bowel Diseases', Gastrointestinal Disorders, 3, http://dx.doi.org/10.3390/gidisord3030010

Bryant RV; Day AS; McGrath KC; Telfer K; Yao CK; Costello SP, 2021, 'Fecal microbiota transplantation augmented by a sulfide-reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis', Jgh Open, 5, pp. 1099 - 1102, http://dx.doi.org/10.1002/jgh3.12623

Vernon-Roberts A; Day AS, 2021, 'Editorial: trends in paediatric inflammatory bowel disease attributable direct costs', Alimentary Pharmacology and Therapeutics, 53, pp. 1232 - 1233, http://dx.doi.org/10.1111/apt.16373

Vernon-Roberts A; Gearry RB; Day AS, 2021, 'Overview of Self-Management Skills and Associated Assessment Tools for Children with Inflammatory Bowel Disease', Gastrointestinal Disorders, 3, pp. 61 - 77, http://dx.doi.org/10.3390/gidisord3020007

Lopez RN; Day AS, 2021, 'The Loneliness of Long-Term Thiopurine Monotherapy for Patients with Inflammatory Bowel Disease', Digestive Diseases and Sciences, 66, pp. 1390 - 1391, http://dx.doi.org/10.1007/s10620-020-06512-y

Shaoul R; Day AS, 2021, 'An Overview of Tools to Score Severity in Pediatric Inflammatory Bowel Disease', Frontiers in Pediatrics, 9, http://dx.doi.org/10.3389/fped.2021.615216

Davis R; Day A; Barrett J; Vanlint A; Andrews JM; Costello SP; Bryant RV, 2021, 'Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study', Journal of Human Nutrition and Dietetics, 34, pp. 420 - 428, http://dx.doi.org/10.1111/jhn.12812

Day AS; Davis R; Costello SP; Yao CK; Andrews JM; Bryant RV, 2021, 'The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic Review', Journal of the Academy of Nutrition and Dietetics, 121, pp. 688 - 708.e3, http://dx.doi.org/10.1016/j.jand.2020.12.001

Zhen J; Stefanolo JP; de la Paz Temprano M; Seiler CL; Caminero A; de-Madaria E; Huguet MM; Santiago V; Niveloni SI; Smecuol EG; Dominguez LU; Trucco E; Lopez V; Olano C; Mansueto P; Carroccio A; Green PH; Duerksen D; Day AS; Tye-Din JA; Bai JC; Ciacci C; Verdú EF; Lebwohl B; Pinto-Sanchez MI, 2021, 'Risk perception and knowledge of COVID-19 in patients with celiac disease', World Journal of Gastroenterology, 27, pp. 1213 - 1225, http://dx.doi.org/10.3748/wjg.v27.i12.1213

Ho SSC; Ross M; Keenan JI; Day AS, 2021, 'Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children', Frontiers in Pediatrics, 8, http://dx.doi.org/10.3389/fped.2020.609279

Zhen J; Stefanolo J; Montoro M; Uscanga L; Day A; Tye-Din J; Ciacci C; Lebwohl B; Pinto-Sanchez MI, 2021, 'A11 RISK PERCEPTION AND KNOWLEDGE OF COVID-19 IN PATIENTS WITH CELIAC DISEASE', Journal of the Canadian Association of Gastroenterology, 4, pp. 12 - 14, http://dx.doi.org/10.1093/jcag/gwab002.010

Appleton L; Day AS, 2021, 'Disease-Related Knowledge in New Zealand Children with Inflammatory Bowel Disease (IBD) and Their Parents', Gastrointestinal Disorders, 3, pp. 23 - 28, http://dx.doi.org/10.3390/gidisord3010002

Roberts AJ; Day AS; Sinclair J; Dickson N; Porter J; Wellington G; Evans HM, 2021, 'Paediatric eosinophilic oesophagitis in New Zealand: A 3-year prospective study', Journal of Paediatrics and Child Health, 57, pp. 234 - 238, http://dx.doi.org/10.1111/jpc.15183

Day AS; Wood JA; Halmos EP; Bryant RV, 2021, 'Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic', Journal of the Academy of Nutrition and Dietetics, 121, pp. 201 - 209, http://dx.doi.org/10.1016/j.jand.2020.07.019

Back to profile page